Your Catalyst To a Lucrative Business
Laparoscopic , surgical , and percutaneous procedures are the various treatment procedures of the tumor ablation market . The surgical procedure sector held a large amount of market share ( 38.0 %) in 2015 . This can be attributed to open surgeries related to breast and liver cancer . However , the percutaneous procedure sector is said to experience a significant growth during 2015 to 2022 owing to the growing demands for minimally invasive procedures .
The key applications of tumor ablation include several cancers such as breast , liver , prostate , lung , kidney , ENT cancer etc . The liver cancer sector held the largest share in 2015 and is further expected to grow during the forecast period . On the other hand , the lung cancer sector is expected to experience tremendous growth owing to the factors such as rising smoking incidences , air pollution and deskbound lifestyle .
Geographically , the tumor ablation market is separated into Middle East & Africa , North America , Asia-Pacific ( APAC ), Europe , and Latin America . The North America region dominated the market with over 32 % share in 2015 . The APAC region is estimated to record the fastest CAGR over the forecast period . The improving healthcare infrastructures in APAC is said to spur market growth in this region in the coming years .
The major participants of the tumor ablation market are Galil Medical Inc ., HealthTronics , Angiodynamics , Boston Scientific Corporation , and SonaCare Medical .
Browse Related Category Market Reports @ https :// www . hexaresearch . com / research-category / medicaldevices-industry
Follow Us :